InsiderOfficer
John E Kao Insider Trading Activity
Every SEC Form 4 transaction reported by John E Kao, sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Is John E Kao buying or selling?
John E Kao reported 1 open-market buys ($496.8K) and 49 sells ($135.1M) across 50 Form 4 filings at 1 company — a net selling position of $134.6M.
Source: SEC EDGAR Form 4
Key Statistics (as of Aug 10, 2026)
Total Form 4 filings
50
SEC EDGAR
Companies
1
Buys (1)
$496.8K
Sells (49)
$135.1M
Insider sentiment
Net sellingNet insider flow of $134.6M in net selling, filed between Oct 15, 2021 – Aug 10, 2026.
Companies John E Kao files for
| # | Company | Form 4 filings |
|---|---|---|
| 1 | ALHCAlignment Healthcare, Inc. | 50 |
Recent John E Kao transactions
| Date | Ticker | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Aug 10, 2026 | ALHC | Chief Executive Officer | Sale | 298.0K | $4.1M |
| Jul 14, 2026 | ALHC | Chief Executive Officer | Sale | 298.0K | $5.9M |
| Jun 12, 2026 | ALHC | Chief Executive Officer | Sale | 298.0K | $6.1M |
| May 13, 2026 | ALHC | Chief Executive Officer | Sale | 298.0K | $5.0M |
| Apr 13, 2026 | ALHC | Chief Executive Officer | Sale | 298.0K | $6.2M |
| Apr 8, 2026 | ALHC | Chief Executive Officer | Sale | 250.0K | $5.3M |
| Mar 23, 2026 | ALHC | Chief Executive Officer | Sale | 118.0K | $2.1M |
| Mar 19, 2026 | ALHC | Chief Executive Officer | Sale | 73.0K | $1.3M |
| Mar 13, 2026 | ALHC | Chief Executive Officer | Sale | 48.9K | $853.1K |
| Mar 10, 2026 | ALHC | Chief Executive Officer | Sale | 180.0K | $3.3M |
| Feb 11, 2026 | ALHC | Chief Executive Officer | Sale | 180.0K | $3.7M |
| Jan 14, 2026 | ALHC | Chief Executive Officer | Sale | 180.0K | $3.8M |
| Dec 30, 2025 | ALHC | Chief Executive Officer | Sale | 605.6K | $11.4M |
| Dec 12, 2025 | ALHC | Chief Executive Officer | Sale | 180.0K | $3.4M |
| Nov 12, 2025 | ALHC | Chief Executive Officer | Sale | 180.0K | $2.9M |
| Oct 14, 2025 | ALHC | Chief Executive Officer | Sale | 180.0K | $3.1M |
| Sep 11, 2025 | ALHC | Chief Executive Officer | Sale | 535.0K | $8.8M |
| Aug 13, 2025 | ALHC | Chief Executive Officer | Sale | 180.0K | $2.6M |
| Jul 11, 2025 | ALHC | Chief Executive Officer | Sale | 180.0K | $2.4M |
| Jun 17, 2025 | ALHC | Chief Executive Officer | Sale | 90.0K | $1.3M |
| Jun 12, 2025 | ALHC | Chief Executive Officer | Sale | 90.0K | $1.4M |
| May 14, 2025 | ALHC | Chief Executive Officer | Sale | 90.0K | $1.3M |
| Apr 16, 2025 | ALHC | Chief Executive Officer | Sale | 90.0K | $1.7M |
| Mar 29, 2025 | ALHC | Chief Executive Officer | Sale | 34.4K | $616.0K |
| Mar 20, 2025 | ALHC | Chief Executive Officer | Sale | 61.6K | $1.0M |
Showing the 25 most recent filings of 50. Screen every filing.
John E Kao insider trading FAQ
Is John E Kao buying or selling?
Across 50 SEC Form 4 filings, John E Kao reported 1 open-market purchases totaling $496.8K and 49 sales totaling $135.1M — a net selling position of $134.6M.
Which companies does John E Kao file Form 4s for?
John E Kao has reported insider transactions at 1 company, most often Alignment Healthcare, Inc. (ALHC).
How far back does John E Kao's filing history go?
Trabud holds John E Kao's SEC Form 4 filings from Oct 15, 2021 – Aug 10, 2026, sourced directly from SEC EDGAR.
Where does Trabud get John E Kao's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track John E Kao and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener